The Labsim POCT Analyzer portfolio integrates fully‑automatic, semi‑automatic and portable technologies. Delivering reliable performance and high cost‑efficiency, our product line can cater to diverse requirements across different user groups.
Built on an immunochromatographic detection platform, the system is simple to operate and delivers test results within a short time. Reagents can be stored at room temperature without the need for a cold chain, facilitating distribution and use. It supports a broad test menu, including assays for infectious diseases, inflammatory markers, cardiac markers, hormones, and tumor markers.
Labsim intelligent pathology printers cover three mainstream printing technologies available on the market: UV laser, infrared laser and thermal transfer. Featuring compact footprint, reliable performance and high resolution printing, the printers are compatible with commonly used consumables. The printed characters are resistant to corrosion from various chemical solutions and can be preserved long term, enabling full process traceability of pathological specimen information.
Labsim's tissue cassettes and microscope slides are compatible with mainstream pathology printers; printed characters are clear, easily legible, and resistant to peeling or discoloration. The printing surface withstands corrosion from common laboratory chemical reagents, ensuring suitability for long-term storage.
Founded in 2007, Guangzhou Labsim Biotech Co., Ltd. is a high-tech manufacturer specializing in automated fluorescence immunoassay systems, POCT solutions, and pathology products.
Guided by our mission to “Make Medical Testing More Accurate” and “Make Pathology Easier,” we provide reliable, integrated solutions for global IVD companies, clinical laboratories, and pathology departments.
In China, Labsim offers one of the most comprehensive portfolios of POCT and pathology products. Our instruments are used by more than 100,000 hospitals and clinics.
More than 500 cooperative customers
Morethan 30% of R&D team
More than 300 patents
Product sales of more than 200,000 pcs
Pathology laboratories process high volumes of specimens, tissue cassettes, and microscope slides every day. Manual handwriting of identification numbers is prone to transcription errors, illegible markings, and low efficiency, creating significant risks for quality control and patient safety. In addition, handwritten labels and paper stickers do not provide durable, traceable records of specimen information, making long-term data retention, tracking, and traceability difficult. These practices do not meet the increasingly stringent requirements for modern pathology laboratory management.
Set up ambitions to create a foundation to add color to Labsim, set lofty aspirations to write the spring and autumn and the sun and the moon, the delicate flower baskets and the bright red carpet welcome the guests from all over the world, the door welcomes hundreds of blessings and boundless wealth, and the housewarming is auspicious.
MEDICA, as the largest and most influential international exhibition for medical equipment, was held in Dusseldorf, Germany from 14th to 17th November, 2022.
From July 8 to 10, 2026, WHX Labs 2026 was successfully held in Bangkok, the capital of Thailand. Labsim showcased its pathology printers as well as POCT immunochromatography analyzers and supporting reagents. The booth drew an endless stream of visitors, with numerous core products attracting industry merchants for on-site consultations and in-depth business negotiations.
